Capabilities · Semi-solids & specialised presentations

Suppositories & pessaries

A proposed service scope for moulded solid presentations, connecting base melting, active ingredient dispersion, shell filling and controlled cooling.

PlannedCatalogue scope

Illustrative unbranded aluminium tube nozzle detail.
Illustrative unbranded aluminium tube nozzle detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Suppository and pessary production is presented as a planned service domain. The exact formulation, moulding requirements, presentation format and specific technical route would establish the boundaries for any such scope.

The initial Boten plan covers sterile injectable presentations and protein raw-material production. Moulded dosage forms represent a proposed catalogue expansion, meaning this scope is outside the initial plan and would need separate confirmation.

Base crystallisation, melting point controls and cavity filling represent distinct technical subjects. Inclusion in this catalogue does not establish that appropriate cooling matrices would be suitable for a given formulation.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Lipophilic suppositoriesFatty base formulations requiring precise thermal profiles to manage crystallisation.Catalogue scopePlanned
Hydrophilic pessariesWater-soluble base matrices requiring controlled blending and moisture-sensitive handling operations.Catalogue scopePlanned
Primary packagingPrimary packagingForming, filling and sealing operations for individual plastic or foil cavities.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Base melting and preparation

Establish thermal parameters for melting the continuous phase without degrading specific structural properties.

02 · Process stage

Planned

Active ingredient dispersion

Define necessary mechanical shear to distribute the active pharmaceutical ingredient within the melted base.

03 · Process stage

Planned

Cavity forming and filling

Consider thermal tolerances and dosing accuracy required when dispensing liquid product into primary shells.

04 · Process stage

Planned

Controlled cooling and solidification

Establish exact time and temperature parameters for the cooling tunnel to control product crystallisation.

05 · Process stage

Planned

Sealing and physical inspection

Define closure mechanisms for the moulded cavity and acceptable criteria for final visual appearance.

06 · Process stage

Planned

Testing and batch review

Connect thermal processing records, dissolution results and uniformity data to the accountable disposition decision.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Primary packaging

Blisters, bottles, sachets, tubes and presentation-specific container systems.

Explore proposed scope

02PlannedCatalogue scope

Raw-material & finished-product testing

Material identity, specifications and product-specific test scope.

Explore proposed scope

03PlannedCatalogue scope

Process development & scale-up

Process definition, scale considerations and the evidence needed for transfer.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product formulation
Exact base composition, active loading and intended melting point specifications.
Facility and systems
Appropriate processing areas, jacketed vessels and qualified cooling tunnel matrices.
Process evidence
Established parameters for melting, dosing and solidification under controlled conditions.
Quality responsibilities
Agreed accountability for component release, uniformity testing and batch review.
Regulatory context
Applicable permissions covering the intended manufacturing activity and delivery route.
Technical agreement
Established boundaries defining responsibilities and exact information exchange for future engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating suppository or pessary production service.

Are moulded formats in the initial plan?

No. The initial Boten plan covers sterile injectable presentations and protein raw-material production. Suppositories and pessaries are proposed catalogue additions requiring separate scope confirmation.

What information helps define the question?

Identify the formulation, base type, presentation, development stage, destination and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established for moulded forms. Project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, specific thermal evidence and any technical agreement would need to be established before a service could exist.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma